The Access-to-Treatment research initiative of the Population Council's Horizons program undertook 11 projects across Asia and sub-Saharan Africa from 2002 to 2008. The projects included a variety of cross-sectional exploratory studies, situation analyses, and longitudinal randomized, controlled intervention studies that examined service delivery, community awareness, health-seeking behaviors, adherence, cost, and other factors affecting treatment for adults and children infected with human immunodeficiency virus (HIV). This article summarizes the key findings and lessons learned from these projects, and examines cross-cutting issues such as stigma, quality of life, and sexual-risk behaviors among people living with HIV and acquired immunodeficiency syndrome on antiretroviral therapy. The article concludes with recommendations for evidence-based programming and future research around treatment for both children and adults.
Van DamJHutchinsonSA. Access to treatment for HIV/AIDS: Report of a meeting of international experts, 2001 Jun 12–13, Washington. Horizons Final Report [cited 2008 Mar 10]. Available from: URL: http://www.popcouncil.org/pdfs/horizons/accessto-treatment.pdf
4.
PanpanichRSornchaiPSuwanteerangkulKJThamthitiwatSSounthisombutP. A rapid situation analysis of the Access to Care Project in northern Thailand. Horizons Final Report. Washington: Population Council; 2004. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/thaisituationanalysis.pdf [cited 2008 Mar 10].
5.
SarnaAGuptaIPujariSSengarAKGargRWeissE. Examining adherence and sexual behavior among patients on antiretroviral therapy in India. Horizons Final Report. Washington: Population Council; 2004. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/indiaart.pdf [cited 2008 Mar 10].
6.
SarnaAPujariSSengarAKGargRGuptaIDamJ. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res2008;127:28–36.
7.
KiraguKSchenkKMurugiJSarnaA. If you build it, will they come? Kenya healthy start pediatric HIV study: A diagnostic study investigating barriers to HIV treatment and care among children. Horizons Final Report. Washington: Population Council; 2008.
8.
MichaelsDEleyBNdhlovuLRutenbergN. Exploring current practices in pediatric ARV rollout and integration with early childhood programs in South Africa: A rapid situation analysis. Horizons Final Report. Washington: Population Council; 2006. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/sapedssa.pdf [cited 2008 Mar 10].
9.
NdholvuLSearleCMillerRFisherASnymanESloanN. Reproductive health services in KwaZulu Natal, South Africa: A situation analysis study focusing on HIV/AIDS services. Horizons Final Report. Washington: Population Council; 2003. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/kznsitanls.pdf [cited 2008 Mar 10].
10.
NdhlovuLMaphangaTMadikizelaLRutenbergN. Exploring models of delivering antiretroviral therapy and integration of ART with TB services in South Africa. Horizons Final Report. Washington: Population Council [forthcoming].
11.
MahendraVSMudoiROinamAPakkelaVSarnaAPandaS. Continuum of care for HIV-positive women accessing programs to prevent parent-to-child transmission: Findings from India. Horizons Final Report. Washington: Population Council; 2007. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/IndiaPPTCT.pdf [cited 2008 Mar 10].
12.
SarnaAHawkenMKaaiS. Acceptability of a modified directly observed therapy approach to improve adherence to antiretroviral therapy. Horizons Research Summary. Washington: Population Council; 2004.
13.
Horizons/Population Council; International Centre for Reproductive Health; Coast Province General Hospital, Mombasa, Kenya. Adherence to antiretroviral therapy in adults: A guide for trainers. Nairobi: Population Council; 2004.
14.
MunyaoPSarnaALuchtersSGeibelSShikelyKMandaliyaK. How feasible is a DAART strategy to promote adherence to ART? Lessons from Mombasa, Kenya. Horizons Research Update. Nairobi: Population Council; 2005.
15.
SarnaALuchtersSGeibelSChersichMFMunyaoPKaaiS. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomised trial. J Acquir Immune Defic Syndr2008;48:611–9.
SamuelsFSimbayaJSarnaAGiebelSNdubaniPKamwangaJ. Engaging communities in supporting HIV prevention and adherence to antiretroviral therapy in Zambia. Horizons Research Summary. Washington: Population Council; 2008.
18.
BergerBEFerransCELashleyFR. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Res Nurs Health2001;24:518–29.
19.
KaaiSSarnaALuchtersSGeibelSMunyaoPMandaliyaK. Changes in stigma among a cohort of people on antiretroviral therapy: Findings from Mombasa, Kenya. Horizons Research Update. Nairobi: Population Council; 2007.
20.
SarnaALuchtersSKaaiSMunyaoPGeibelSShikelyK. Does being treated with HAART affect the sexual risk behavior of people living with HIV/AIDS? Insights from Mombasa, Kenya. Horizons Research Update. Nairobi: Population Council; 2005.
21.
SarnaALuchtersSMGeibelSKaaiSMunyaoPShikelyKS. Sexual risk behaviour and HAART: A comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya. Int J STD AIDS2008;19:85–9.
22.
LuchtersSSarnaAGeibelSChersichMMunyaoPKaaiS. Sexual risk behaviors of HIV-positive persons receiving ART in Mombasa, Kenya: Longitudinal study findings. Horizons Research Summary. Nairobi: Population Council; 2007.
23.
LuchtersSSarnaAGeibelSChersichMFMunyaoPKaaiS. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: A prospective cohort. AIDS Patient Care STDS2008;22:587–94.
24.
OberdorferPChariyalertsakSThapintaDSuwantherangoonJGuestPWuA. Changes in sexual behavior of people living with HIV after 12 months of antiretroviral therapy: Experiences from Thailand. Presented at the 16th International AIDS Conference; 2006 Aug 13–18; Toronto.
25.
National Institutes of Health, National Institute of Allergy and Infectious Diseases. Adult AIDS clinical trials group, adult quality of life forms: Baseline and follow-up adherence modules [cited 2008 Jan 15]. Available from: URL: https://www.fstrf.org/apps/cfmx/apps/actg/html/QOLForms/index.html
26.
BeckATBrownGKSteerRA. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.
WuAWRevickiDAJacobsonDMalitzFE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res1997;6:481–93.
29.
NieuwkerkPTOortFJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. J Acquir Immune Defic Syndr2005;38:445–8.
30.
LiuHGolinCEMillerLGHaysRDBeckCKSanandajiS. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med2001;134:968–77.
31.
MillerRFisherAMillerKNdhlovuLMaggwaB NduggaAskewI. The situation analysis approach to assessing family planning and reproductive health services: A handbook. New York: Population Council; 1997.
32.
FarmerPLéandreFMukherjeeJSClaudeMNevilPSmith-FawziMC. Community-based approaches to HIV treatment in resource-poor settings. Lancet2001;358:404–9.
33.
SeverePLegerPCharlesMNoelFBonhommeGBoisG. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med2005;353:2325–34.
34.
AlticeFLMaruDSBruceRDSpringerSAFriedlandGH. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clin Infect Dis2007;45:770–8.
35.
AlticeFLMezgerJAHodgesJBruceRDMarinovichAWaltonM. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clin Infect Dis2004;38Suppl 5:S376–87.
36.
MacalinoGEMittyJABazermanLBSinghKMcKenzieMFlaniganT. Modified directly observed therapy for the treatment of HIV-seropositive substance users: Lessons learned from a pilot study. Clin Infect Dis2004;38Suppl 5:S393–7.
37.
FischlM. Directly observed therapy for HIV therapy in corrections: Ready or not? [abstract 528]. Presented at the 8th Conference on Retroviruses and Opportunistic Infections; 2001 Feb 4–8; Chicago.
38.
WohlDAStephensonBLGolinCEKiziahCNRosenDNgoB. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis2003;36:1572–6.
39.
WohlARGarlandWHValenciaRSquiresKWittMDKovacsA. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis2006;42:1619–27.
40.
PearsonCRMicekMSimoniJMMatedianaEMartinDPGloydS. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr2006;43Suppl 1: S134–41.
41.
GillCJHamerDHSimonJLTheaDMSabinLL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS2005;19:1243–9.
42.
BakariAGSani-BelloFShehuMSMaiAAliyuISLawalII. Antiretroviral therapy induced diabetes in a Nigerian. Afr Health Sci2007;7:133–5.
43.
WandHCalmyACareyDLSamarasKCarrALawMG. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS2007;21:2445–53.
44.
JainRGFurfineESPedneaultLWhiteAJLenhardJM. Metabolic complications associated with antiretroviral therapy. Antiviral Res2001;51:151–77.
